Survey of Resident Education in Intensity-Modulated Radiation Therapy
Introduction
Intensity-modulated radiation therapy (IMRT) is a novel approach to the planning and delivery of radiation (1). Unlike conventional approaches, IMRT conforms the prescription dose to the shape of the target in three-dimensions, thereby sparing the surrounding normal tissues. Highly conformal IMRT plans may thus reduce the risk of and also provide a means of potentially escalating dose in select patients improving tumor control (6) . IMRT also may provide the ability to deliver a second course of treatment in previously irradiated patients (7, 8) .
IMRT is becoming increasingly popular in the radiation oncology community. Previously available at only a few academic centers, a recent survey revealed that approximately one-third of practicing radiation oncologists in the United States currently use IMRT (9) . Clinical implementation is occurring at a rapid rate, with 80% of IMRT-users having only adopted it in the prior 24 months. Moreover, >95% of non-users planned to implement it in the near future.
Given its growing popularity, it is not surprising that numerous IMRT "schools", seminars, and workshops have appeared. Some are sponsored by academic centers (10) (11) (12) (13) (14) (15) . Others are offered by professional societies, including the American Society for Therapeutic Radiology and Oncology (ASTRO) (16), American College of Radiation Oncology (ACRO) (17), and the American Association for Physicists in Medicine (AAPM) (18) . Some are even offered by vendors and private companies (19, 20) .
Despite the plethora of educational opportunities in IMRT available for the practicing radiation oncologist, it remains unclear to what extent IMRT is being taught to residents in radiation oncology training programs. To explore this issue, we conducted a survey of radiation oncology residents in the United States. The results of this survey and implications of our findings are presented here.
Materials and Methods

Study Population
Chief residents at all 77 accredited radiation oncology residency programs in the United States (as of 1/04) were sent surveys by e-mail or fax. Association of Residents in Radiation Oncology (ARRO) and ASTRO directories were used to identify programs and chief residents. If the chief resident did not reply after two attempts, a third and final survey was addressed to a randomly selected senior resident at the respective program. Chief/Senior residents were targeted since they would have a broader view of their program's didactics and clinical experience. If still no response was obtained, these institutions were designated as "non-responders". All non-respondent institutions were then contacted to determine whether IMRT was currently in use at that institution. However, no further effort was made to assess their IMRT didactics and clinical IMRT experience.
Survey
A 13-question survey was designed to assess didactic teaching and hands-on resident training in IMRT (Table I) .
Accompanying the survey was a cover letter outlining the purpose of the project and the confidential nature of the results. Our intention of evaluating resident education in IMRT with inverse planning was described.
In addition to inquiring about the frequency of IMRT didactics (number of lectures, seminars, et cetera per year), residents were asked about the subject presented (physics, clinical medicine, radiobiology) and the didactic format (lecture, journal club, seminar, et cetera). Didactics were designated as extensive (≥3 lectures, journal clubs, seminars per year), moderate (1-2 lectures, journal clubs, seminars per year), or limited (1-2 lectures during the entire residency). Characteristics of hands-on training included the number and anatomical sites treated with IMRT, involvement in the IMRT process (patient selection, simulation, defining target volumes, plan generation, plan evaluation, and/or quality assurance), and intent of IMRT use (conventional dosing, dose escalation). Finally, the survey assessed residents' opinions regarding both their didactic teaching and hands-on experience.
The survey was intentionally designed to be brief (5-10 minutes) and to be completed by the resident alone. Consequently, it did not include detailed questions regarding IMRT software and hardware or approaches to specific diseases.
Statistical Analysis
The survey was conducted and analyzed between April 2003 and February 2004. For the purposes of this analysis, based on the number of total residents, programs were designated as "small" (≤ 8) or "large" (≥ 9). Moreover, we used OVID and MEDLINE searches to determine whether a program was based at a department whose faculty has published on IMRT (physics and/or clinical studies).
Survey results are presented as a percentage of responses. Differences in proportions between various groups were analyzed using the chi-square test. Significant values were defined as those with p < 0.05.
Results
Completed surveys were received from residents at 61 of the 77 accredited radiation oncology programs, giving a response rate of 79%. Over 98% of respondents were at minimum in their 4 th post-graduate year of training; 77% were in their 5 th post-graduate year. The percentages of respondents at small programs and at institutions whose faculty has published on IMRT were 72% and 49%, respectively. Of note, all 16 non-respondent residents were at institutions currently using IMRT in the clinic.
IMRT Didactics
Overall, 71% of respondents reported receiving formal IMRT didactics during their residency training. Of these, the percentages of respondents who characterized their didactics as extensive, moderate, or limited were 30%, 54%, and 16%, respectively. Residents at institutions currently using IMRT clinically were more likely to receive formal IMRT didactics (79 vs. 13%, p < 0.0001) than those at institutions not using IMRT. In addition, formal didactics were more common at centers whose faculty have published on IMRT (83 vs. 58%, p = 0.031) than at centers without IMRT publications. There was no correlation between program size and IMRT didactics.
IMRT didactics were most commonly provided by medical physicists. The percentages of respondents with formal didactics who reported involvement by physicists, attending physicians, or radiobiologists were 98%, 63%, and 7%, respectively. Of those reporting involvement of medical physicists, nearly one-third reported physicists as their sole source of IMRT didactics. The most common didactic formats were lectures (95%) and journal clubs (63%). Seven percent reported having had more unique IMRT didactics, e.g., case presentations.
The majority of respondents (70%) with IMRT didactics desired an increase in didactics while 30% felt that their current level was appropriate. Of note, none desired a reduction. Attitudes regarding increasing IMRT didactics reflected their current level. The percentages of respondents who desired an increase in didactics whose present didactics were limited, moderate, or extensive were 100%, 87%, and 23%, respectively (p < 0.0001).
Hands-On Training
The proportion of respondents who reported hands-on IMRT experience was 87%. Overall, 79% of respondents with hands-on training also reported receiving formal didactics. The percentage of programs with neither hands-on exposure nor formal didactics was 12%.
The percentages of residents with hands-on IMRT experience who reported having treated <10, 11-25, or >25 IMRT patients were 36%, 19%, and 45%, respectively. Hands-on training was more common at centers having published on IMRT (100 vs. 74% p = 0.003) than at those without IMRT publications. No correlation was seen between hands-on training and program size. Figure 1 summarizes the sites treated with IMRT. The most common were head and neck cancers and genitourinary tumors. However, many respondents reported having treated central nervous system, pediatric, and gynecologic tumors. Moreover, nearly one quarter reported having treated a palliative patient with IMRT. Table II summarizes the involvement in the IMRT process by residents with hands-on experience. Nearly all participated in target and tissue delineation (98%) and plan evaluation (93%). Involvement was also common in patient selection (83%), simulation (87%), and plan generation (85%). Of note, approximately one-quarter reported participating in the quality assurance (QA) process.
Nearly all residents with hands-on IMRT experience reported using IMRT to deliver conventional doses (93%); 41% of these reported having only delivered conventional doses. Sixty percent reported using IMRT for dose escalation with 9% of these using it solely for dose escalation.
Of residents with hands-on IMRT experience, 51% felt that their experience was adequate. A total of 47% desired an increase in hands-on training and 2% desired a decrease. Attitudes regarding hands-on experience reflected current clinical experience. The percentages of respondents who desired an increase in clinical experience who had treated ≤10, 11-25, or >25 patients were 84%, 40%, and 21% respectively (p < 0.0001).
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Discussion
The purpose of this study was to evaluate radiation oncology resident education in IMRT. To this end, we surveyed residents at all accredited radiation oncology residency programs in the United States. Our results reveal that the great majority of radiation oncology residents in this country are currently exposed to this technology in the form of both didactics and hands-on training.
Most respondents reported receiving formal IMRT didactics, with nearly one-third reporting extensive didactics. Formal didactics were more common at centers currently using IMRT clinically and at those performing IMRT research, most likely reflecting faculty experience and interests. We were surprised that there was no correlation between IMRT didactics and program size, given that program size is a surrogate for faculty size. However, all that is needed for a didactic program is a few interested, dedicated faculty.
It is not surprising that nearly all residents at programs with formal IMRT didactics reported teaching by medical physicists. The myriad of physics issues pertaining to IMRT is considerable and is best presented by physicists. However, nearly one-third of respondents with formal didactics reported teaching solely by physicists. IMRT is much more than a new technology. It is a fundamentally new approach to all aspects of radiation oncology. Residents need to be exposed to its medical aspects in addition to its technical aspects. Which patients should receive IMRT? Which should not? What are the tradeoffs between target coverage and normal tissue sparing? What are the consequences of increased low dose to normal tissues? These and other issues are presumably discussed by the attending with the resident in the clinic as they pertain to a particular case. However, given the demands of a busy clinic, such issues should also be presented outside the confines of the clinic. Unless such issues are presented and discussed, residents are less likely to apply IMRT appropriately in their future practices.
A concerning finding relating to IMRT didactics was the almost non-existent involvement of radiation biologists. This was true even at programs with large radiobiology faculties (mea culpa). Multiple biological issues are raised by IMRT, e.g., concerns about secondary malignancies (1, 21). Moreover, given the ability to "dose paint", IMRT treatment plans can be optimized based on tumor biology (22, 23) . Clearly, radiobiologists need to be involved in the didactic process if residents are to be exposed to the full benefits and risks of IMRT as well as to novel biologically-based treatment approaches.
One of the more disconcerting observations in our study is that nearly one-third of residents who reported hands-on IMRT training had either no or only limited formal IMRT didactics. When residents are soon faced with the responsibility to not only plan but to also select specific IMRT patients, if IMRT is to be properly applied, it is essential that it be incorporated into the didactic program of the residency.
A notable finding is that 87% of respondents reported handson experience with IMRT. If non-respondent institutions are included, the true percentage may be as high as 90% (since all non-respondent institutions use IMRT). This is a somewhat surprising result given that this technology has only recently become widely available. In our earlier survey of practicing radiation oncologists (9), less than one-half of academic physicians surveyed reported using IMRT, raising the question whether current residents were being exposed to this technology. That survey, however, was conducted nearly 2 years ago and assessed physician not institutional use.
The possibility that many academic physicians were at centers with IMRT although they did not themselves use it may also account for this difference. Furthermore, use among respondents may only reflect recent training instead of that which has occurred over the entire span of residency training.
Most respondents reported considerable experience in nearly all aspects of the IMRT process from patient selection to plan evaluation. Such experience is imperative if residents are to appropriately select and apply IMRT in the future. Moreover, their experience spans a wide spectrum of disease sites. By far, the most common tumors were head and neck cancers and genitourinary tumors (presumably mainly prostate cancer). This is not surprising given the large number of promising IMRT studies in head and neck (24-28) and genitourinary (6, (29) (30) (31) (32) tumors performed at many of these same institutions. Given the increasing interest using IMRT in brain (33-35), gynecologic (4, 36-38) , and pediatric (4) tumors, it is also not surprising that a fair number of residents have experience in these sites.
A comparison of disease sites reported by residents in this survey and those reported by practicing radiation oncologists in our earlier survey is shown in Table III . The three most common sites (head and neck, genitourinary, brain) were reported with almost identical frequencies. In addition, the frequency of breast and lymphoma were similar. However, three sites (gastrointestinal, gynecology, and pediatrics) were more common in the resident survey, most notably pediatrics. This is not surprising given that that residents surveyed were at academic centers, many with protocols focusing on IMRT. Interestingly, considerably fewer residents reported having treated lung cancer with IMRT compared to practicing physicians. Because the earlier survey included both academic and private physicians, the difference noted in these sites may reflect referral patterns. It remains unclear how experience gained by residents will translate into sites they treat in their future practice. Presumably, increased comfort in a wide variety of tumor sites and situations, including palliative patients, will expand the clinical application of IMRT in the community.
Nearly all current residents have used IMRT to deliver conventional doses with nearly one-half having only used it to deliver conventional doses. However, 60% have used IMRT to escalate dose. This finding was expected given that dose escalation is a common motivation for adopting IMRT (9). Moreover, many academic centers are actively evaluating dose escalation with IMRT in a number of disease sites including prostate cancer (6, 29) and head and neck tumors (28). Hopefully, such experience during residency will help ensure the safe delivery of higher than conventional doses in their future practices. Nonetheless, dose escalation remains unproven in the majority of disease sites and is best delivered under the auspices of a clinical trial.
An interesting finding was that residents desire more didactics and more hands-on experience. Reasons for this may be multi-factorial. First of all, many respondents had only minimal didactics and/or hands-on IMRT experience. However, increases were desired even by those residents with moderate/extensive didactics and hands-on experience. Such desires are consistent with the findings of the 2002 ARRO survey in which 98% of respondents desired an increase in didactic lectures by attending physician staff (39). Of note, an increase in IMRT training was not as desired as an increase in IMRT didactics.
Clearly, this study has a number of limitations. First of all, we relied on self-report of IMRT use, which may not accurately reflect reality. Some respondents may have construed IMRT as any modulation of the treatment beam, although it was clearly stated in the cover letter that we were interested in inversely planned IMRT. We also did not provide strict definitions of such issues as dose escalation and quality assurance. Differences in how individual respondents interpreted these issues may have altered our results.
It is also possible that residents at programs without handson experience (or didactics) may have felt compelled to state that their program had formal didactics and hands-on experience given the current popularity of IMRT and the increasingly competitive environment of the radiation oncology match. Finally, the brevity of our survey has inherent limitations. For example, it did not assess whether physicians (many with Ph.D.s and considerable basic science experience) gave lectures on the radiobiology of IMRT in lieu of radiobiologists. Moreover, our brief survey did not allow us to assess what is being taught. A more detailed format would be needed to assess the topics and quality of IMRT education at each program.
This study is the first to address resident education in IMRT.
Our results suggest that IMRT education is common in most residency programs in the United States. Moreover, it identifies both strengths (breadth of clinical experience) and weaknesses (less extent of involvement of physicians and biologists in didactics) in resident IMRT education. Hopefully, these results will help improve resident IMRT training, ensuring that this technology is applied discriminately and safely in the future.
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